Press Releases for MSFT

Press Releases
InSite Vision Announces FDA Advisory Committee’s Unanimous Recommendation of Approval for New Ophthalmic Product Enabled by InSite’s DuraSite® Technology
InSite Vision Receives Notification Letter from NYSE Alternext US
InSite Vision Announces Preliminary Results From Phase 3 Clinical Trial of ISV-502 for the Treatment of Eyelid Inflammation and Infection
InSite Vision Announces Corporate Restructuring To Focus on Growth Opportunities and Conserve Resources
InSite Vision Reports Third Quarter 2008 Financial Results
InSite Vision Names Louis Drapeau Interim CEO
InSite Vision to Announce Third Quarter 2008 Financial Results and Hold Conference Call on November 6, 2008
InSite Vision and PTV Sciences Announce Preliminary Voting Results at Annual Meeting
InSite Vision Claims PTV Sciences Misrepresents Facts
PTV Sciences Urges All Stockholders to Vote the GOLD Card at InSite Vision's Annual Meeting Scheduled for Monday, September 22, 2008
PROXY Governance, Inc. Joins RiskMetrics and Glass Lewis in Recommending Stockholders Vote PTV Sciences' GOLD Proxy Card
InSite Vision Strongly Disagrees with Recommendation of Proxy Advisory Firm; Urges Stockholders to Support Board Nominees
RiskMetrics (ISS), An Independent Proxy Advisory Firm, Recommends Voting the GOLD Card for Four of PTV's Nominees: Anderson, McInerney, Melrose, and O'Holla
Proxy Advisory Firm Rejects Entire Management Slate of InSite Vision, Including the Chairman and Chief Executive Officer
InSite Vision Announces Proxy Advisory Firm's Recommendation of Only One Director Member from Dissident's Slate
InSite Vision Announces Webcast of Presentation at The Wall Street Analyst Forum's 19th Annual Institutional Investor Conference
Revised Analyst Reports for Metalico Inc., Five Star Quality Care Inc., InSite Vision Incorporated, and Storm Cat Energy Corporation
InSite Vision Reports Second Quarter 2008 Financial Results
InSite Vision to Announce Second Quarter 2008 Financial Results and Hold Conference Call on August 11, 2008
InSite Vision Signs AzaSite(R) Licensing and Distribution Agreement with Essex Bio-Technology for People's Republic of China
InSite Vision to Provide Corporate Presentation at the Informed Investors Biotech/Healthcare/Pharma Virtual Forum
InSite Vision Reports First Quarter 2008 Results
InSite Vision Signs AzaSite(R) Licensing and Distribution Agreement with Biem Pharmaceuticals for Turkey
InSite Vision to Announce First Quarter 2008 Financial Results and Hold Conference Call on May 8, 2008
InSite Vision Appoints New Vice President of Operations